GlassScriptPhysician profile
Donovan Edward Perry
NPI 1205577871
$3,472.77
in general payments reported to CMS, 2019-2025
12 companies · $3,473 in 2025
The $3,473 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $3,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Travel and Lodging: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,906.08 |
| Travel and Lodging | $1,566.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $960.98 | 2025 | Biobrace 23mm |
| Integra Lifesciences Corporation | $625.75 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Arthrex, INC. | $548.55 | 2025 | |
| Southern Edge Orthopaedics, INC. | $265.11 | 2025 | |
| Smith+Nephew, INC. | $243.32 | 2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Kerecis Limited | $162.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $152.62 | 2025 | Infinity Adaptis, N/A |
| Access Pro Medical, LLC | $151.32 | 2025 | Matriderm |
| Solventum Corporation | $133.42 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Pacira Pharmaceuticals Incorporated | $123.63 | 2025 | Exparel |
| Treace Medical Concepts, INC. | $64.07 | 2025 | |
| Paragon 28, INC. | $41.72 | 2025 | Apex 3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donovan Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.